Media Library

View from Kleinbasel towards Novartis Campus Basel

Bird's eye view, Novartis Pavillon

Main entrance, Novartis Pavillon

Board member since March 2023

The Novartis in Society Integrated Report covers our business, strategy and performance. It highlights progress against our ESG targets and describes how we create value for diverse stakeholders. This is the German version of the report.

Manufacturing RNA therapies in Schweizerhalle, Switzerland

View of RNA production in Schweizerhalle, Switzerland

Production process of RNA therapies in Schweizerhalle, Switzerland

Discover the data published in The Lancet on the long-term effect of Cosentyx® (secukinumab) in adults with hidradenitis suppurativa from the SUNRISE and SUNSHINE trials.

The Novartis in Society Integrated Report covers our business, strategy and performance. It highlights progress against our ESG targets and describes how we create value for diverse stakeholders.

This report, filed with the SIX Swiss Exchange in Switzerland, provides a comprehensive overview of Novartis, including our company structure, corporate governance and compensation practices. It also discloses our operating and financial results, accompanied by audited annual financial statements.

The global malaria burden and the achievements Novartis accomplished in the fight against it to date.